[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 437 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 437

  To provide for research on antiprogestin drugs through the National 
                         Institutes of Health.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 5, 1993

 Mr. Wyden (for himself, Mr. Waxman, Mrs. Schroeder, and Mr. DeFazio) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To provide for research on antiprogestin drugs through the National 
                         Institutes of Health.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Antiprogestin Testing Act of 1993''.

SEC. 2. RESEARCH.

    (a) In General.--The Secretary of Health and Human Services, acting 
through the Director of the National Institutes of Health, may conduct 
and support research (including clinical trials) on antiprogestin drugs 
for their safety and efficacy for any potential use, including 
termination of pregnancy and contraception, and when used 
therapeutically for cancer, endocrine disorders, and endometriosis.
    (b) Institutional Review Boards and Peer Review.--Research 
conducted or supported under subsection (a) shall be subject to 
sections 491 and 492 of the Public Health Service Act (42 U.S.C. 289, 
289a).
    (c) Priorities.--In determining priorities for research under 
subsection (a), the Secretary shall consider data from previous 
research.

SEC. 3. REPORT.

    The Secretary of Health and Human Services shall report to Congress 
the results of research conducted or supported under section 2(a) on 
January 1, 1994, and annually thereafter.

                                 <all>